Published by Benjamin Chiou on 19th May 2025
(Sharecast News) - GSK's Blenrep treatment has been approved by Japanese regulators when in combination for relapsed or refractory multiple myeloma, marking the second major approval of its kind for the drug, with more expected in 2025.
URL: http://www.digitallook.com/dl/news/story/35088920/...